跳至主要内容
临床试验/NL-OMON36140
NL-OMON36140招募中不适用

Optimalization of the response to influenza virus vaccination in breast cancer and colorectal cancer patients immunocompromised due to chemotherapy - Ofluvac

Sint Antonius Ziekenhuis0 个研究点目标入组 190 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
190

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Patients with breast cancer treated FEC- or TAC-containing triweekly chemotherapy at moment of vaccination.
  • 2. Patients with colorectal cancer treated with Oxaliplatin-containing triweekly chemotherapy at moment of vaccination
  • 3.Age >= 18 years
  • 4. Signing informed consent

排除标准

  • 1. Fever at time of vaccination defined as a temperature of >= 38.5 °C.
  • 2. Previous/known allergic reaction to any of the components of the vaccines given, for example hypersensitivity to egg protein
  • 3. Thrombocytopenia (defined as < 50 * 109/L) at moment of vaccination

研究者

相似试验